OUTLOOK THERAPEUTICS, INC. Dividends, Preferred Stock
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Dividends, Preferred Stock of $462.91 thousand for the 9-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Shareholders' Equity
us-gaap:DividendsPreferredStock · last filed 2019-08-14
- OUTLOOK THERAPEUTICS, INC. dividends, preferred stock for the quarter ending 2019-06-30 was $158.13K.
- OUTLOOK THERAPEUTICS, INC. dividends, preferred stock for the quarter ending 2019-03-31 was $154.27K, a 76.40% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. dividends, preferred stock for the quarter ending 2018-12-31 was $150.51K, a 66.61% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. dividends, preferred stock for the quarter ending 2018-06-30 was -$451.87K.
- OUTLOOK THERAPEUTICS, INC. dividends, preferred stock for fiscal 2017 was $16.98K.
| Period end | Dividends, Preferred Stock 3 month | Dividends, Preferred Stock 6 month | Dividends, Preferred Stock 6 month as first filed | Dividends, Preferred Stock 9 month | Dividends, Preferred Stock 12 month |
|---|---|---|---|---|---|
| 2019-06-30 | $158.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $312.40K derived: sum of 2 quarters · filed 2019-08-14 | $462.91K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $154.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | $304.78K 10-Q · filed 2019-05-15 | |||
| 2018-12-31 | $150.51K 10-Q · filed 2019-02-14 | ||||
| 2018-06-30 | -$451.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $201.81K derived: sum of 2 quarters · filed 2019-08-14 | $652.61K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $653.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | $1.10M 10-Q · filed 2019-05-15 | $0.00 10-Q · filed 2018-05-15 | ||
| 2017-12-31 | $450.80K 10-Q · filed 2019-02-14 | ||||
| 2017-09-30 | $16.98K 10-K · filed 2017-12-29 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |